What drugs does APOTHECON make?

APOTHECON has 78 FDA-approved drugs.

What therapeutic areas does APOTHECON focus on?

APOTHECON focuses primarily on Infectious Disease and Dermatology and 1 other therapeutic areas.

← Back

Data updated: Jun 28, 2026

APOTHECON

Specialty

Infectious Disease Dermatology Cardiovascular

APOTHECON is a specialty pharmaceutical company focused on Infectious Disease, Dermatology, Cardiovascular.

1950

Since

Drugs

Trials

New Drugs (2yr)

Modality:

3 Small Molecules

APOTHECON's Key Drugs

APOTHECON's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

APOTHECON's Recent FDA Approvals

APOTHECON secured 1 new FDA approval for novel drugs (NDA/BLA) in the last two years.

FAMOTIDINE NDA

2025-07-16

famotidine

1 INDICATIONS AND USAGE Famotidine tablets are indicated in adult and pediatric patients 40 kg and greater for the treatment of: • active duodenal ulcer (DU). • active gastric ulcer (GU). • symptomatic nonerosive gastroesophageal reflux disease (GERD). • erosive esophagitis due to GERD, diagnosed by biopsy. Famotidine tablets are indicated in adults for the: • treatment of pathological hypersecretory conditions (e.g., Zollinger-Ellison syndrome, multiple endocrine neoplasias). • reduction of the risk of duodenal ulcer recurrence. Famotidine tablets are a histamine-2 (H 2 ) receptor antagonist indicated ( 1 ): In adult and pediatric patients 40 kg and greater for the treatment of: • active duodenal ulcer (DU). • active gastric ulcer. • symptomatic nonerosive gastroesophageal reflux disease (GERD). • erosive esophagitis due to GERD, diagnosed by biopsy. In adults for the: • treatment of pathological hypersecretory conditions (e.g., Zollinger-Ellison syndrome, multiple endocrine neoplasias). • reduction of the risk of DU recurrence.

APOTHECON's Therapeutic Areas

APOTHECON's approved drugs and pipeline span 5 therapeutic areas, led by Infectious Disease and Dermatology, across 0 biologic and 3 small-molecule drugs. Weighted by commercial stage — approved drugs count most, then late-stage trials.

Infectious Disease 33%

5 drugs

Dermatology 27%

4 drugs

Cardiovascular 20%

3 drugs

Gastroenterology 13%

2 drugs

Respiratory 7%

1 drugs

APOTHECON's Top Competitors

APOTHECON's closest competitors by therapeutic-area and drug-target overlap include Merck, Baxter, and MALLINCKRODT. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.

Merck big-pharma

Infectious Disease, Cardiovascular, Respiratory

Baxter specialty

Infectious Disease, Cardiovascular, Dermatology

MALLINCKRODT specialty

Respiratory, Gastroenterology, Cardiovascular, Dermatology

Bayer big-pharma

Cardiovascular, Respiratory, Dermatology

B BRAUN specialty

Infectious Disease, Dermatology, Cardiovascular